Amundi Vericel Corp Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Vericel Corp stock. As of the latest transaction made, Amundi holds 19,867 shares of VCEL stock, worth $803,818. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,867
Previous 24,568
19.13%
Holding current value
$803,818
Previous $1.35 Million
34.32%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$326 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$141 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$117 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$98.6 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$92 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.91B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...